Anavotx
Leiden, NL · 25 employees on LinkedIn · 4 known investors
Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.
Founders & leadership
BZ
Birgit ZechCEO
Investors · 4
Frequently asked questions
- What does Anavotx do?
- Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.
- Who are Anavotx's investors?
- Anavotx's investors include Taiho Ventures, LLC, Bioqube Ventures, Inkef, M Ventures.
- Where is Anavotx headquartered?
- Anavotx is headquartered in Leiden, NL.